id: NEW:aod_medication_treatment_to_alcohol_use_disorder
name: Alcohol/Other Drug Use Disorder Medication â†’ Alcohol Use Severity
from_node:
  node_id: NEW:aod_medication_treatment
  node_name: Alcohol/Other Drug Use Disorder Medication
to_node:
  node_id: alcohol_use_disorder
  node_name: Alcohol Use Severity
direction: negative
category: healthcare_access
mechanism_pathway:
- 'Step 1: Individuals with alcohol use disorder receive pharmacologic treatment (e.g.,
  naltrexone, acamprosate, disulfiram) targeting neurobiological mechanisms of addiction'
- 'Step 2: AOD medications reduce cravings, block rewarding effects of alcohol, or
  create aversive reactions to alcohol consumption'
- 'Step 3: Pharmacologic intervention leads to decreased alcohol consumption and reduced
  alcohol use severity at end of treatment'
evidence:
  quality_rating: A
  n_studies: 24
  primary_citation: 'Denise A. Hien et al. 2023. "Project harmony: A systematic review
    and network meta-analysis of psychotherapy and pharmacologic trials for comorbid
    posttraumatic stress, alcohol, and other drug use disorders." Psychological bulletin.'
  supporting_citations: []
description: Network meta-analysis of 24 RCTs found that AOD medication treatment
  significantly reduces alcohol use severity compared to placebo (SMD = -0.36). Effects
  were stronger when AOD medication was combined with trauma-focused psychotherapy
  (SMD = -0.50 vs placebo, SMD = -0.81 vs trauma-focused therapy + placebo), particularly
  in populations with comorbid PTSD.
last_updated: '2025-12-02'
extraction_method: consolidated_batch_v3
quantitative_effects:
  effect_size:
    value: -0.36
    type: standardized_mean_difference
    ci_lower: null
    ci_upper: null
  p_value: null
  sample_size: null
moderators:
- name: Combination with trauma-focused psychotherapy
  direction: strengthens
  strength: strong
  description: Trauma-focused psychotherapy combined with AOD medication showed larger
    effects (SMD = -0.50 to -0.81) compared to medication alone (SMD = -0.36)
- name: Comorbid PTSD
  direction: weakens
  strength: moderate
  description: Individuals with co-occurring PTSD and AOD may require integrated treatment
    approaches for optimal outcomes
